Comparative analysis of cerebrospinal fluid metabolites in Alzheimer's disease and idiopathic normal pressure hydrocephalus in a Japanese cohort.
Yuki NagataAkiyoshi HirayamaSatsuki IkedaAoi ShirahataFutaba ShojiMidori MaruyamaMitsunori KayanoMasahiko BundoKotaro HattoriSumiko YoshidaYu-Ichi GotoKatsuya UrakamiTomoyoshi SogaKouichi OzakiShumpei NiidaPublished in: Biomarker research (2018)
This study identified four metabolites that could possibly discriminate between AD and iNPH, which previous research has shown are closely related to the risk factors, pathogenesis, and symptoms of AD. Analyzing pathway-specific metabolites in the CSF of patients with AD may further elucidate the mechanism and pathogenesis of AD.